Bharat Biotech

Govt Aims To Vaccinate All Citizens By Year-End, Targets 216 Cr Doses By Dec - Check Rollout Plan

COVID Vaccine: DCGI Approves Phase 2/3 Clinical Trial Of Covaxin In Age Group Of 2 To 18 Yrs

BJP Clears Air On Centre's Vaccine Export, Says 84% Doses Sent Abroad Part Of Licensing Liabilities

Vaccine Shortage: SII To Ramp Up Production To 10 Cr Doses By Aug, Bharat Biotech Promises 7.8 Cr Jabs

Covaxin Centres In Delhi Closed As Bharat Biotech Refused To Supply Vaccines On Centre's Directive: AAP

Bharat Biotech Gets Approval To Start Next Phase Of Clinical Trials Of 'Covaxin' On Children Aged 2-18 Years

Fresh Orders Placed To Procure Covid-19 Vaccines, To Be Delivered By July: Hardeep Singh Puri

Reports Alleging No Fresh Order Has Been Placed For Covid-19 Vaccines Are ‘Incorrect’: Health Ministry

Bharat Biotech Slashes Covaxin Prices From Rs 600 To Rs 400 Per Dose For States

Covid-19 Vaccines Uniform Rate: Bombay HC Refuses To Hear PIL, Asks Petitioners To Approach SC

'Covaxin Can Neutralise 617 Variant Of Covid-19,' Claims Dr Fauci; US Working On Sending Supplies To India

Bharat Biotech Seeks DCGI’s Permission To Extend Shelf Life Of Covid-19 Vaccine 'COVAXIN'